GeneBioTech Co. ,Ltd Statistics

Total Valuation

GeneBioTech Co. ,Ltd has a market cap or net worth of KRW 29.66 billion. The enterprise value is 22.20 billion.

Market Cap	29.66B
Enterprise Value	22.20B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

GeneBioTech Co. ,Ltd has 8.61 million shares outstanding. The number of shares has decreased by -0.18% in one year.

Current Share Class	n/a
Shares Outstanding	8.61M
Shares Change (YoY)	-0.18%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	28.78%
Owned by Institutions (%)	n/a
Float	6.09M

Valuation Ratios

The trailing PE ratio is 12.22.

PE Ratio	12.22
Forward PE	n/a
PS Ratio	0.37
PB Ratio	0.60
P/TBV Ratio	n/a
P/FCF Ratio	16.72
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.67, with an EV/FCF ratio of 12.52.

EV / Earnings	9.15
EV / Sales	0.28
EV / EBITDA	4.67
EV / EBIT	6.53
EV / FCF	12.52

Financial Position

The company has a current ratio of 2.93, with a Debt / Equity ratio of 0.32.

Current Ratio	2.93
Quick Ratio	1.95
Debt / Equity	0.32
Debt / EBITDA	3.34
Debt / FCF	8.97
Interest Coverage	5.46

Financial Efficiency

Return on equity (ROE) is 5.03% and return on invested capital (ROIC) is 3.36%.

Return on Equity (ROE)	5.03%
Return on Assets (ROA)	3.11%
Return on Capital (ROIC)	3.36%
Revenue Per Employee	2.22B
Profits Per Employee	67.39M
Employee Count	36
Asset Turnover	1.17
Inventory Turnover	4.12

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.06% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-21.06%
50-Day Moving Average	3,484.10
200-Day Moving Average	3,877.68
Relative Strength Index (RSI)	40.20
Average Volume (20 Days)	1,058,032

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GeneBioTech Co. ,Ltd had revenue of KRW 80.03 billion and earned 2.43 billion in profits. Earnings per share was 282.00.

Revenue	80.03B
Gross Profit	13.15B
Operating Income	3.40B
Pretax Income	2.89B
Net Income	2.43B
EBITDA	4.76B
EBIT	3.40B
Earnings Per Share (EPS)	282.00

Full Income Statement

Balance Sheet

The company has 23.37 billion in cash and 15.91 billion in debt, giving a net cash position of 7.46 billion or 866.55 per share.

Cash & Cash Equivalents	23.37B
Total Debt	15.91B
Net Cash	7.46B
Net Cash Per Share	866.55
Equity (Book Value)	49.42B
Book Value Per Share	5,738.97
Working Capital	35.95B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.07 billion and capital expenditures -294.63 million, giving a free cash flow of 1.77 billion.

Operating Cash Flow	2.07B
Capital Expenditures	-294.63M
Free Cash Flow	1.77B
FCF Per Share	206.02

Full Cash Flow Statement

Margins

Gross margin is 16.44%, with operating and profit margins of 4.25% and 3.03%.

Gross Margin	16.44%
Operating Margin	4.25%
Pretax Margin	3.61%
Profit Margin	3.03%
EBITDA Margin	5.94%
EBIT Margin	4.25%
FCF Margin	2.22%

Dividends & Yields

GeneBioTech Co. ,Ltd does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.18%
Shareholder Yield	0.18%
Earnings Yield	8.19%
FCF Yield	5.98%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GeneBioTech Co. ,Ltd has an Altman Z-Score of 3.53.

Altman Z-Score	3.53
Piotroski F-Score	n/a